About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

StemCell Institute(7096) Summary

7096
TSE Growth
StemCell Institute
1,310
JPY
+106
(+8.80%)
Apr 10, 3:30 pm JST
8.92
USD
Apr 10, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
26.6
PBR
4.98
Yield
1.91%
Margin Trading Ratio
12.69
Stock Price
Apr 10, 2025
Opening Apr 10, 9:06 am
1,294 JPY 8.77 USD
Previous Close Apr 9
1,204 JPY 8.28 USD
High Apr 10, 11:19 am
1,333 JPY 9.08 USD
Low Apr 10, 9:09 am
1,262 JPY 8.56 USD
Volume
11,300
Trading Value
0.02B JPY 0.10M USD
VWAP
1304.9 JPY 8.9 USD
Minimum Trading Value
131,000 JPY 892 USD
Market Cap
0.01T JPY 0.09B USD
Number of Trades
78
Liquidity & Number of Trades
As of Apr 10, 2025
Liquidity
Mid
1-Year Average
102
1-Year High Feb 27, 2025
952
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 4, 2025 27,700 97,700 3.53
Mar 28, 2025 30,700 103,600 3.37
Mar 21, 2025 35,300 111,600 3.16
Mar 14, 2025 37,200 115,200 3.10
Mar 7, 2025 32,200 138,200 4.29
Company Profile
StemCell Institute operates a cell bank business for regenerative medicine, focusing on the separation and storage of umbilical cord blood. It is part of the Nihon Trim Group.
Sector
Services
StemCell Institute develops a cell bank business for regenerative medicine and cell therapy. The company separates and stores cells derived from perinatal tissues such as umbilical cord blood and umbilical cords for future medical treatments. Umbilical cord blood contains hematopoietic stem cells and mesenchymal cells, and clinical research is progressing on regenerative medicine and cell therapy for pediatric central nervous system diseases and autism spectrum disorders. StemCell Institute has cell processing centers in Tokyo and Yokohama, and a cell storage center in Yokohama, with various certifications including a license for manufacturing specific cell products. In addition to umbilical cord blood storage, the company has also launched umbilical cord tissue storage services. StemCell Institute is also engaged in the development of regenerative medicine products and business development and investment in related fields.